XML 48 R37.htm IDEA: XBRL DOCUMENT v3.25.0.1
Restructuring, Impairment, and Related Charges, Net - Schedule of Restructuring Charges (Details) - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2024
Dec. 31, 2023
Restructuring Cost and Reserve [Line Items]        
Severance and employee-related costs, net $ (5) $ (7) $ 143 $ 5
Exit and other-related costs 30 11 50 51
Asset impairments and accelerated depreciation 7 0 83 28
Total 32 4 276 84
Restructuring, impairment, and related charges, net 32 4 213 84
Cost of Sales        
Restructuring Cost and Reserve [Line Items]        
Restructuring, impairment, and related charges, net     63  
U.S. Pharmaceutical | Cost of Sales        
Restructuring Cost and Reserve [Line Items]        
Restructuring, impairment, and related charges, net     63  
Operating Segments | U.S. Pharmaceutical        
Restructuring Cost and Reserve [Line Items]        
Severance and employee-related costs, net 1 (6) 2 3
Exit and other-related costs 0 1 0 3
Asset impairments and accelerated depreciation 1 0 65 0
Total 2 (5) 67 6
Operating Segments | Prescription Technology Solutions        
Restructuring Cost and Reserve [Line Items]        
Severance and employee-related costs, net 0 1 0 1
Exit and other-related costs 0 1 3 6
Asset impairments and accelerated depreciation 0 0 2 0
Total 0 2 5 7
Operating Segments | Medical-Surgical Solutions        
Restructuring Cost and Reserve [Line Items]        
Severance and employee-related costs, net (6) 0 138 0
Exit and other-related costs 19 3 25 9
Asset impairments and accelerated depreciation 6 0 6 0
Total 19 3 169 9
Operating Segments | International        
Restructuring Cost and Reserve [Line Items]        
Severance and employee-related costs, net 0 0 0 2
Exit and other-related costs 1 0 0 9
Asset impairments and accelerated depreciation 0 0 1 1
Total 1 0 1 12
Corporate        
Restructuring Cost and Reserve [Line Items]        
Severance and employee-related costs, net 0 (2) 3 (1)
Exit and other-related costs 10 6 22 24
Asset impairments and accelerated depreciation 0 0 9 27
Total $ 10 $ 4 $ 34 $ 50